Skip to main content
PTCT logo
PTCT
(NASDAQ)
PTC Therapeutics, Inc.
$69.30-- (--)
Loading... - Market loading

PTC Therapeutics (PTCT) Stock Price & Financial Analysis

PTC Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$69.26 - $71.41
52-Week High$90.87
52-Week Low$56.51
Open$70.62
Volume673.54K
Average Volume (3M)1.06M
Market Cap6.38B
Shares Outstanding92.02M
Price to Sales (P/S)6.32
Price to Book (P/B)-38.56
EV/EBITDA81.53
Revenue (TTM)1.01B
Net Income (TTM)-38.38M
Free Cash Flow (TTM)-327.53M
EPS (TTM)$-0.45
Profit Margin-3.80%
Operating Margin11.52%
50-Day MA$75.82
200-Day MA$73.35
52-Week Change21.03%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About PTC Therapeutics

What is the current stock price for PTCT?

As of the latest trading session, PTCT stock trades at $69.30. The 52-week range is $56.51–$90.87, with a day range of $69.26–$71.41.

What is the P/E ratio for PTCT?

The P/E ratio (Price-to-Earnings) for PTCT is shown in the Key Statistics section. This valuation metric helps compare PTC Therapeutics, Inc. to industry peers.

Does PTCT pay dividends?

PTC Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PTCT?

Based on 2 analysts, the consensus for PTCT is Buy.

What is the market cap of PTCT?

PTC Therapeutics's market capitalization is $6.38B, classifying it as a mid-cap company. PTC Therapeutics operates in the Healthcare sector within the Biotechnology industry.